407 related articles for article (PubMed ID: 25263788)
41. Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive/stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid.
Zhang Y; Yang C; Yuan G; Wang Z; Cui W; Li R
Int J Mol Med; 2015 Jan; 35(1):263-70. PubMed ID: 25384498
[TBL] [Abstract][Full Text] [Related]
42. Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid.
Deckmann I; Schwingel GB; Fontes-Dutra M; Bambini-Junior V; Gottfried C
Neuroimmunomodulation; 2018; 25(5-6):285-299. PubMed ID: 30157484
[TBL] [Abstract][Full Text] [Related]
43. Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment.
Campolongo M; Kazlauskas N; Falasco G; Urrutia L; Salgueiro N; Höcht C; Depino AM
Mol Autism; 2018; 9():36. PubMed ID: 29946415
[TBL] [Abstract][Full Text] [Related]
44. Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus.
Bristot Silvestrin R; Bambini-Junior V; Galland F; Daniele Bobermim L; Quincozes-Santos A; Torres Abib R; Zanotto C; Batassini C; Brolese G; Gonçalves CA; Riesgo R; Gottfried C
Brain Res; 2013 Feb; 1495():52-60. PubMed ID: 23219577
[TBL] [Abstract][Full Text] [Related]
45. Altered attentional processing in male and female rats in a prenatal valproic acid exposure model of autism spectrum disorder.
Anshu K; Nair AK; Kumaresan UD; Kutty BM; Srinath S; Laxmi TR
Autism Res; 2017 Dec; 10(12):1929-1944. PubMed ID: 28851114
[TBL] [Abstract][Full Text] [Related]
46. GABAergic synaptic transmission and cortical oscillation patterns in the primary somatosensory area of a valproic acid rat model of autism spectrum disorder.
Fontes-Dutra M; Righes Marafiga J; Santos-Terra J; Deckmann I; Brum Schwingel G; Rabelo B; Kazmierzak de Moraes R; Rockenbach M; Vendramin Pasquetti M; Gottfried C; Calcagnotto ME
Eur J Neurosci; 2023 Feb; 57(3):527-546. PubMed ID: 36504470
[TBL] [Abstract][Full Text] [Related]
47. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
Ishola IO; Balogun AO; Adeyemi OO
Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
[TBL] [Abstract][Full Text] [Related]
48. Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism.
Edalatmanesh MA; Nikfarjam H; Vafaee F; Moghadas M
Brain Res; 2013 Aug; 1526():15-25. PubMed ID: 23806776
[TBL] [Abstract][Full Text] [Related]
49. Indifference of marmosets with prenatal valproate exposure to third-party non-reciprocal interactions with otherwise avoided non-reciprocal individuals.
Yasue M; Nakagami A; Banno T; Nakagaki K; Ichinohe N; Kawai N
Behav Brain Res; 2015 Oct; 292():323-6. PubMed ID: 26133500
[TBL] [Abstract][Full Text] [Related]
50. Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid.
Roullet FI; Wollaston L; Decatanzaro D; Foster JA
Neuroscience; 2010 Oct; 170(2):514-22. PubMed ID: 20603192
[TBL] [Abstract][Full Text] [Related]
51. Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally.
Barrett CE; Hennessey TM; Gordon KM; Ryan SJ; McNair ML; Ressler KJ; Rainnie DG
Mol Autism; 2017; 8():42. PubMed ID: 28775827
[TBL] [Abstract][Full Text] [Related]
52. Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid.
Servadio M; Manduca A; Melancia F; Leboffe L; Schiavi S; Campolongo P; Palmery M; Ascenzi P; di Masi A; Trezza V
Eur Neuropsychopharmacol; 2018 Jan; 28(1):85-96. PubMed ID: 29174949
[TBL] [Abstract][Full Text] [Related]
53. Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism.
Al-Askar M; Bhat RS; Selim M; Al-Ayadhi L; El-Ansary A
BMC Complement Altern Med; 2017 May; 17(1):259. PubMed ID: 28486989
[TBL] [Abstract][Full Text] [Related]
54. Social behavior, neuroimmune markers and glutamic acid decarboxylase levels in a rat model of valproic acid-induced autism.
Win-Shwe TT; Nway NC; Imai M; Lwin TT; Mar O; Watanabe H
J Toxicol Sci; 2018; 43(11):631-643. PubMed ID: 30404997
[TBL] [Abstract][Full Text] [Related]
55. Animal model of autism using GSTM1 knockout mice and early post-natal sodium valproate treatment.
Yochum CL; Bhattacharya P; Patti L; Mirochnitchenko O; Wagner GC
Behav Brain Res; 2010 Jul; 210(2):202-10. PubMed ID: 20178820
[TBL] [Abstract][Full Text] [Related]
56. G protein-coupled estrogen receptor (GPER) selective agonist G1 attenuates the neurobehavioral, molecular and biochemical alterations induced in a valproic acid rat model of autism.
Hameed RA; Ahmed EK; Mahmoud AA; Atef AA
Life Sci; 2023 Sep; 328():121860. PubMed ID: 37331505
[TBL] [Abstract][Full Text] [Related]
57. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
Matsuo K; Yabuki Y; Fukunaga K
Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
[TBL] [Abstract][Full Text] [Related]
58. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats.
Kumar H; Sharma B
Brain Res; 2016 Jan; 1630():83-97. PubMed ID: 26551768
[TBL] [Abstract][Full Text] [Related]
59. Quercetin prevents alterations of behavioral parameters, delta-aminolevulinic dehydratase activity, and oxidative damage in brain of rats in a prenatal model of autism.
de Mattos BDS; Soares MSP; Spohr L; Pedra NS; Teixeira FC; de Souza AA; Stefanello FM; Baldissarelli J; Gamaro GD; Spanevello RM
Int J Dev Neurosci; 2020 Jun; 80(4):287-302. PubMed ID: 32181519
[TBL] [Abstract][Full Text] [Related]
60. Increased sociability and gene expression of oxytocin and its receptor in the brains of rats affected prenatally by valproic acid.
Štefánik P; Olexová L; Kršková L
Pharmacol Biochem Behav; 2015 Apr; 131():42-50. PubMed ID: 25662821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
